Stocktoria
PALVELLA THERAPEUTICS, INC. PVLA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-12-18
PALVELLA THERAPEUTICS, INC. statistics & valuation
Market cap$2.1B
P / B76.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | -27.7% | -167.8% | -165.0% |
| Net margin | — | — | 43.7% | -128.5% | -145.6% |
| FCF margin | — | — | -32.4% | -235.4% | -27.4% |
| Return on assets | -70.0% | -19.8% | 247.6% | -34.8% | -29.8% |
| Return on equity | -149.1% | -27.8% | -25.1% | 35.5% | -90.1% |
| Current ratio | 5.20 | 7.33 | 3.20 | 2.01 | 2.52 |
| Revenue growth | — | — | 65.3% | -17.6% | 7.1% |
Source: SEC EDGAR filings · CIK 0001583648 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.